231 related articles for article (PubMed ID: 29353208)
1. Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
Feng WW; Kuang SY; Tu C; Ma ZJ; Pang JY; Wang YH; Zang QC; Liu TS; Zhao YL; Xiao XH; Wang JB
Biomed Pharmacother; 2018 Mar; 99():325-333. PubMed ID: 29353208
[TBL] [Abstract][Full Text] [Related]
2. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
3. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone.
Sakr HF; Hussein AM; Eid EA; AlKhateeb M
Steroids; 2018 Jul; 135():21-30. PubMed ID: 29674209
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
[TBL] [Abstract][Full Text] [Related]
6. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
7. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
Al Zarzour RH; Ahmad M; Asmawi MZ; Kaur G; Saeed MAA; Al-Mansoub MA; Saghir SAM; Usman NS; Al-Dulaimi DW; Yam MF
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718838
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.
Yan HM; Xia MF; Wang Y; Chang XX; Yao XZ; Rao SX; Zeng MS; Tu YF; Feng R; Jia WP; Liu J; Deng W; Jiang JD; Gao X
PLoS One; 2015; 10(8):e0134172. PubMed ID: 26252777
[TBL] [Abstract][Full Text] [Related]
9. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Hua Tan Qu Shi decoction against liver injury in rats with nonalcoholic fatty liver disease.
Zhao SP; Wu ZS; Chen Y; Liang X; Bao L; Li P; Sun RR; Wu YL; Li LR; Wang Q
Biomed Pharmacother; 2017 Jul; 91():181-190. PubMed ID: 28458156
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
12. [Effect of curcumin on intestinal mucosal mechanical barrier in rats with non-alcoholic fatty liver disease].
Hou HT; Qiu YM; Zhao HW; Li DH; Liu YT; Wang YZ; Su SH
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):134-138. PubMed ID: 28297801
[No Abstract] [Full Text] [Related]
13. [Intervention of berberine on lipid deposition in liver cells of non-alcoholic fatty liver disease rats induced by high fat diet].
Han L; Yang QH; Zhang YP; Yan HZ; Zhu XF; Gong XW; Jin L; Wang PP; Liu YZ; Liang YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):314-9. PubMed ID: 25951637
[TBL] [Abstract][Full Text] [Related]
14. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893
[TBL] [Abstract][Full Text] [Related]
16. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
17. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
[TBL] [Abstract][Full Text] [Related]
19. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice.
Xue M; Zhang L; Yang MX; Zhang W; Li XM; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2015; 10():5049-57. PubMed ID: 26346310
[TBL] [Abstract][Full Text] [Related]
20. Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice.
Chen Y; Jiang Z; Xu J; Zhang J; Sun R; Zhou J; Lu Y; Gong Z; Huang J; Shen X; Du Q; Peng J
J Nanobiotechnology; 2021 Aug; 19(1):230. PubMed ID: 34348707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]